Bringing the fundamentals into focus…
Back to Ultragenyx Pharmaceutical Inc.
How Ultragenyx Pharmaceutical Inc. stacks up
RARE · against 553 other Healthcare companies listed in US-listed
Overall
24/ 100
Near the bottom of its peers.
Ranked #489 of 554 · scores higher than 9% of peers
Bars: peers in each 10-point band of the overall score70 peers with an overall score of 20–29, including RARE · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around RARE| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 563M USD | 97 | 96 | 98 | 99 | 0 / 2 | |
| 1 | 2.2B USD | 97 | 97 | 99 | 93 | 0 / 2 | |
| 1 | 263M USD | 97 | 93 | — | 98 | 0 / 2 | |
| 4 | 1.4B USD | 94 | 96 | 91 | 93 | 0 / 2 | |
| 5 | 625M USD | 91 | 95 | 99 | 99 | 0 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score